Finzati - Logo
LMAT logo

LeMaitre Vascular, Inc.

LMATMedical - Instruments & Supplies
$80.67
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.98B
Growth
8.0%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 23.1%Positive revenue growth · 10.9%Positive free cash flow · 3.29Consistent free cash flow · 5/5Manageable debt level · 0.47
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:01 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$80.67
Change0.00%
Shares Out24.50M
Market Cap$1.98B
Enterprise Value$1.77B
52W Range78.65 - 118.01
Beta0.52
P/E30.10
P/S7.53
P/B4.70
P/FCF26.78
EV/Sales6.74

Investment DNA

How strong this company looks for long-term investors

85
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
93/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score
Stable or improving margins · 23.1%Positive revenue growth · 10.9%Positive free cash flow · 3.29Consistent free cash flow · 5/5Manageable debt level · 0.47Healthy liquidity · 12.89

Analyst view

Analyst sentiment and price target

LMAT
Analyst sentiment
Based on 20 analyst votes · 2026-09-05
85/100
Bullish
Bullish
14
Hold
6
Bearish
0
Price Target
2026-08-07
Low
$95.00
Mean
$115.00
Median
$115.00
High
$135.00

Company Overview

IPO: 10/19/2006
Industry: Medical - Instruments & Supplies
P/B i: 4.70
Debt / Equity i: 0.47
Operating Margin: 27.21%
Net Margin: 23.13%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.47
Current Ratio: 12.89
Quick Ratio: 10.95
Status: Strong

Insider Transactions

Recent executive and insider activity

LeMaitre George W
Transaction: 06/04/2026
BUY
Change
Price
Not reported
Filing
06/05/2026
Type
BUY
LeMaitre George W
Transaction: 06/04/2026
BUY
Change
+11,974
Price
Not reported
Filing
06/05/2026
Type
BUY
Kamke Trent G
Transaction: 06/04/2026
BUY
Change
Price
Not reported
Filing
06/05/2026
Type
BUY